Page last updated: 2024-10-22

acetazolamide and Bone Diseases, Developmental

acetazolamide has been researched along with Bone Diseases, Developmental in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moey, LH1
Flaherty, M1
Zankl, A1
van Dalsem, VF1
Genant, HK1
Newton, TH1

Other Studies

2 other studies available for acetazolamide and Bone Diseases, Developmental

ArticleYear
Optic disc swelling in acromicric and geleophysic dysplasia.
    American journal of medical genetics. Part A, 2019, Volume: 179, Issue:9

    Topics: Acetazolamide; Bone Diseases, Developmental; Child; Child, Preschool; Female; Humans; Limb Deformiti

2019
Progressive diaphyseal dysplasia. Report of a case with thirty-four years of progressive disease.
    The Journal of bone and joint surgery. American volume, 1979, Volume: 61, Issue:4

    Topics: Acetazolamide; Adult; Bone Diseases, Developmental; Camurati-Engelmann Syndrome; Dexamethasone; Huma

1979